Long-term protective immunity against SARS-CoV-2 virus in COVID-19 patients

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 173204

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $267,750
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Ishac Nazy
  • Research Location

    Canada
  • Lead Research Institution

    McMaster University
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The current COVID-19 pandemic is caused by a new coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Current tests are unable to accurately identify patients who are infected or determine the effectiveness of their immune response against the virus. They also cannot identify patients who have produced a protective immune response for combating future re-infection with SARS-CoV-2. There are many question regarding the effects this pandemic has presented our society; however, understanding if individuals are protected against the virus, after being infected, continues to be very important. In this proposal, we will identify how our bodies react to the virus by examining antibodies in the immune system and by studying the memory immune cells that produce antibodies to determine if and how long our bodies are protected against the virus in the future. We will do this by identifying which patients have developed an immune response (antibodies) and then test for their ability to eliminate the SARS-CoV-2 virus, effectively. We will also determine if recovered COVID-19 patients develop memory immune cells capable of fighting re-infections in the future. These tests are important for many reasons, including: 1) accurately diagnose COVID-19 patients by identifying who developed an immune response; 2) identify individuals who mounted strong antibody responses that eliminates the SARS-CoV-2 virus and 3) determine if there is immune memory against COVID-19 that could protect against re-infection. A deeper understanding of the immune response will help fight the current COVID-19 pandemic and better prepare us for future pandemics.